H&R Block Inc (HRB)vsMEDIFAST INC (MED)
HRB
H&R Block Inc
$45.12
+0.53%
CONSUMER CYCLICAL · Cap: $5.56B
MED
MEDIFAST INC
$12.04
-0.08%
CONSUMER CYCLICAL · Cap: $141.66M
Smart Verdict
WallStSmart Research — data-driven comparison
H&R Block Inc generates 1145% more annual revenue ($3.95B vs $316.93M). HRB leads profitability with a 18.6% profit margin vs -8.1%. HRB appears more attractively valued with a PEG of 0.58. HRB earns a higher WallStSmart Score of 67/100 (B-).
HRB
Strong Buy67
out of 100
Grade: B-
MED
Hold45
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-62.9%
Fair Value
$27.71
Current Price
$45.12
$17.41 premium
Intrinsic value data unavailable for MED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 68 in profit
Strong operational efficiency at 32.9%
Growing faster than its price suggests
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Growing faster than its price suggests
Areas to Watch
3.0% revenue growth
4.5% earnings growth
Trading at 47.5x book value
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
ROE of -10.1% — below average capital efficiency
Revenue declined 27.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : HRB
The strongest argument for HRB centers on P/E Ratio, Return on Equity, Operating Margin. Profitability is solid with margins at 18.6% and operating margin at 32.9%. PEG of 0.58 suggests the stock is reasonably priced for its growth.
Bull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, Debt/Equity. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bear Case : HRB
The primary concerns for HRB are Revenue Growth, EPS Growth, Price/Book. Debt-to-equity of 17.89 is elevated, increasing financial risk.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
HRB profiles as a value stock while MED is a turnaround play — different risk/reward profiles.
MED carries more volatility with a beta of 0.70 — expect wider price swings.
HRB is growing revenue faster at 3.0% — sustainability is the question.
HRB generates stronger free cash flow (237M), providing more financial flexibility.
Bottom Line
HRB scores higher overall (67/100 vs 45/100), backed by strong 18.6% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
H&R Block Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
H&R Block, Inc., provides services and products for assisted preparation of income tax returns and self-preparation of income tax returns (DIY) to the general public, primarily in the United States, Canada and Australia. The company is headquartered in Kansas City, Missouri.
MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Compare with Other PERSONAL SERVICES Stocks
Want to dig deeper into these stocks?